Law360, New York (May 14, 2012, 1:27 PM EDT) -- At the last two nanotechnology-focused events I have attended, a common topic of discussion has arisen. People in the industry are noticing that the line that has typically, and clearly, divided semiconductor technology and biotechnology, is now beginning to blur. IP practitioners need to realize that this new semi/bio combination is highly technically complex and that they may need to improve their skills or work with others who have this skill set in order to be effective in this challenging field. Whether it be in the procurement of IP rights, in the handling of transactional matters, or even in litigation, IP practitioners that better understand this growing overlap between semiconductor technology and biotechnology will be able to secure the best possible outcomes for their clients....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
